Analysis. Vekuva's measurement of another outlet's report. The reporting is the outlet's; the framing analysis is ours. · The Hindu
Vekuva’s reading of The Hindu’s report
Bharat Biotech slashes malaria vaccine price on GAVI-backed pact with UNICEF
By The Hindu Bureau||3 min read at The Hindu
In brief
Vaccine maker Bharat Biotech International announced a 40% price reduction for its malaria vaccine Mosqivac following a GAVI-backed agreement with UNICEF.
The deal, supported by an advance payment from the International Finance Facility for Immunisation (IFFIm), will lower the price to €5.50 per dose effective early 2027, aiming to save $50 million for child immunisation programmes and reach one million more children.
The article notes that demand for malaria vaccines has exceeded forecasts and that the vaccine is now part of routine immunisation in 25 African countries.
This is an AI-estimated analysis and may not reflect the article's actual intent or the publisher's editorial position.
Read this page in Telugu · Google Translate (opens translate.google.com in a new tab)Machine translation by Google, not checked by Vekuva
Updated - October 24, 2026 12:02 am IST - HYDERABAD
Vaccine maker Bharat Biotech International on Friday said it is reducing the price of malaria vaccine Mosqivac by about 40% following an agreement executed by UNICEF and financially backed by Gavi, the Vaccine Alliance.
That is the opening of The Hindu’s story. The full report is on their site.
Read the full story at The Hindu (opens in a new tab)